StockNews.AI
QGEN
StockNews.AI
135 days

QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook

1. QIAGEN's Q1 2025 results surpassed sales and earnings expectations. 2. Net sales increased by approximately 5%, exceeding prior guidance.

+5.36%Current Return
VS
-0.18%S&P 500
$38.2604/06 08:04 PM EDTEvent Start

$40.3104/08 02:27 AM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

The strong performance indicates robust demand and operational efficiency, reminiscent of QGEN's previous upward trends during earnings announcements, suggesting continued investor confidence.

How important is it?

Positive earnings results contribute significantly to investor sentiment and stock valuation, making this news highly relevant for QGEN’s price movement.

Why Short Term?

The immediate market reaction to positive earnings results generally impacts stock prices in the short term, positioning QGEN favorably for upward movement until the next earnings report.

Related Companies

VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary Q1 2025 results that exceeded its outlook for both net sales and adjusted earnings per share (EPS), reflecting strong performances across many growth drivers. Net sales grew approximately 5% (+7% at constant exchange rates, CER) to about $483 million in Q1 2025, surpassing the previously communicated outlook for about 3% CER growth (4% CER core business excluding discontinued.

Related News